LEIPER LIFE THERAPIES LIMITEDActive

Company number SC727899Private limited companyIncorporated 2022

Key figures

£272+146.6%
Net assets 2025/26
+4.1%
Average annual growth 2022/23–2025/26
-750-500-25002505002022/232023/242024/252025/26

Like most small UK companies, LEIPER LIFE THERAPIES LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2025/26
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
02.5 k5 k7.5 k2022/232023/242024/252025/26
Filed accounts2022/23–2025/26
2022/232023/242024/252025/26
Total assets5,0786,3945,3297,218
Total liabilities4,1165,6615,1936,136
Net assets / total equity24113-584272
Average number of employees0000

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Principal activity

Accounts 2026

The principal activity of the company during the year under review was Other Human Health Activities.

As described in the company's latest filed accounts.

Summary: LEIPER LIFE THERAPIES LIMITED

Company

LEIPER LIFE THERAPIES LIMITED is a private limited company registered with Companies House under company number SC727899. It was incorporated on 29 Mar 2022. Its status is active. The registered office is in Paisley (PA1). Its nature of business (SIC 2007) is other human health activities (86900).

Accounts

The latest accounts in the database are for 2025/26 (period ending 31 Mar 2026); the company files micro-entity accounts. Net assets were £272, up 146.6% on the previous year. Total assets were £7,218 and total liabilities £6,136. The company had an average of 0 employees. Figures are available for 4 financial years (2022/23–2025/26).

Control and charges

One person with significant control is registered.

Filing deadlines

The next accounts are due by 31 Dec 2027. The next confirmation statement is due by 11 Apr 2027.